| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/1999 | WO1999017607A2 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999007849A3 Human reticulocalbin isoforms |
| 04/15/1999 | WO1999007738A3 Human orphan receptor ntr-1 |
| 04/15/1999 | WO1999006440A8 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 04/15/1999 | WO1999005313A3 Method for typing of minor histocompatibility antigen ha-1 |
| 04/15/1999 | WO1999005300A3 Ghrh expression system and methods of use |
| 04/15/1999 | WO1999005172A3 Pharmaceuticals for modulating hormone responsiveness |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999004746A3 Activated forms of notch and methods based thereon |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999002653A9 Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
| 04/15/1999 | WO1999000412A9 Interferon stimulating protein and uses thereof |
| 04/15/1999 | WO1999000409A9 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 04/15/1999 | WO1999000408A3 Human transmembrane protein from the transmembrane 4 superfamily |
| 04/15/1999 | WO1999000010A3 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 04/15/1999 | WO1998059061A9 Male tissue-preferred regulatory region and method of using same |
| 04/15/1999 | WO1998059058A3 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/15/1999 | WO1998059050A9 Cloning of a gene mutation for parkinson's disease |
| 04/15/1999 | WO1998059048A9 Receptor for a bacillus thuringiensis toxin |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998047343A9 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages |
| 04/15/1999 | WO1998045429A3 Polypeptides involved in the staurosporine induced apoptotic pathway |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE4447664C2 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/15/1999 | DE19821060A1 Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung Co-stimulatory polypeptide of T-cells, monoclonal antibodies and the production and use thereof |
| 04/15/1999 | DE19811047C1 Copper-containing ribonucleoproteins |
| 04/15/1999 | DE19742706A1 Anticaline Anticalins |
| 04/15/1999 | CA2309554A1 Mammalian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2308120A1 Human proteins having transmembrane domains and cdnas encoding these proteins |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2306246A1 Signal peptide containing proteins and uses therefor |
| 04/15/1999 | CA2306182A1 Gene deleted recombinant felv proviral dna for production of vaccines against felv |
| 04/15/1999 | CA2305886A1 Human proteins having transmembrane domains and cdnas encoding these proteins |
| 04/15/1999 | CA2305848A1 Cdnas coding for human proteins having transmembrane domains |
| 04/15/1999 | CA2305814A1 Gankyrin |
| 04/15/1999 | CA2305786A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305711A1 Assays for nuclear receptor ligands using fret |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305707A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
| 04/15/1999 | CA2305689A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305682A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | CA2305620A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | CA2305559A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305441A1 Methods of using ice-controlling molecules |
| 04/15/1999 | CA2305386A1 Proteins alike to human complement factor h and cdnas encoding these proteins |
| 04/15/1999 | CA2305382A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | CA2305337A1 Human proteins having secretory signal sequences and cdnas encoding these proteins |
| 04/15/1999 | CA2305204A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 04/15/1999 | CA2305045A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | CA2304796A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304350A1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | CA2273842A1 A human 2-19 protein homologue, z219a |
| 04/15/1999 | CA2273195A1 Icam-4 and diagnostic uses thereof |
| 04/15/1999 | CA2273186A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
| 04/14/1999 | EP0908727A1 Synuclein-based assay and synuclein protein |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908515A2 Pancreatic polypeptide |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0908466A1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same |
| 04/14/1999 | EP0908093A1 Model transgenic animal for interleukin-1 relevant diseases |
| 04/14/1999 | EP0907887A1 Engineering affinity ligands for macromolecules |
| 04/14/1999 | EP0907886A1 Retinoid x receptors and components of the basal transcription machinery |
| 04/14/1999 | EP0907751A2 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 04/14/1999 | EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0907740A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 04/14/1999 | EP0907739A1 Porcine retrovirus |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907734A2 GALANIN RECEPTOR GalR2 |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907731A1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907724A2 Von willebrand factor multimerase |
| 04/14/1999 | EP0907719A1 Human cytokine polypeptide |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907660A1 Scarecrow gene, promoter and uses thereof |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907377A1 Novel compounds |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907371A1 A synthetic peptide and its uses |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907368A1 Novel heparin binding peptides |